Wensu S. Wei

State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Prognostic impact of lymphovascular invasion and efficacy of adjuvant therapy in patients with non-metastatic clear cell renal cell carcinoma: a single-center retrospective cohort study

Prognostic impact of lymphovascular invasion and efficacy of adjuvant therapy in patients with non-metastatic clear cell renal cell carcinoma: a single-center retrospective cohort study

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: May 27, 2026

Functional and volumetric changes following partial nephrectomy for large (≥ 7 cm) renal masses: a comparative study.

Functional and volumetric changes following partial nephrectomy for large (≥ 7 cm) renal masses: a comparative study.

Journal: World journal of urology

Published: October 12, 2025

Erratum to "Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNA".

Erratum to "Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNA".

Journal: Biomaterials research

Published: September 24, 2025

First-line PD-1 blockades combined with TKIs for metastatic non-clear cell renal cell carcinoma: a real-world multicenter retrospective study.

First-line PD-1 blockades combined with TKIs for metastatic non-clear cell renal cell carcinoma: a real-world multicenter retrospective study.

Journal: Cancer immunology, immunotherapy : CII

Published: April 13, 2025

An Evaluation of HER2 Expression Heterogeneity in Primary Tumors and Metastatic Lymph Nodes of Patients With Advanced Extramammary Paget's Disease: Prognostic and Therapeutic Implications.

An Evaluation of HER2 Expression Heterogeneity in Primary Tumors and Metastatic Lymph Nodes of Patients With Advanced Extramammary Paget's Disease: Prognostic and Therapeutic Implications.

Journal: Cancer medicine

Published: March 18, 2025

Neutrophil-to-lymphocyte ratio predicts a poor prognosis for penile cancer with an immunosuppressive tumor microenvironment.

Neutrophil-to-lymphocyte ratio predicts a poor prognosis for penile cancer with an immunosuppressive tumor microenvironment.

Journal: Frontiers in immunology

Published: January 30, 2025

Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay.

Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay.

Journal: ESMO open

Published: January 23, 2025

Clinical effectiveness and safety of tislelizumab plus TKI as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): a single-center retrospective study.

Clinical effectiveness and safety of tislelizumab plus TKI as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): a single-center retrospective study.

Journal: World journal of urology

Published: October 19, 2024

Enhanced Oxidative Phosphorylation Driven by TACO1 Mitochondrial Translocation Promotes Stemness and Cisplatin Resistance in Bladder Cancer.

Enhanced Oxidative Phosphorylation Driven by TACO1 Mitochondrial Translocation Promotes Stemness and Cisplatin Resistance in Bladder Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 25, 2024

Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy.

Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy.

Journal: International immunopharmacology

Published: May 08, 2024

Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study.

Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study.

Journal: Clinical genitourinary cancer

Published: September 01, 2023

Efficacy and safety evaluation of immunotherapy combined with targeted therapy as second-line treatment in patients with metastatic non-clear cell renal cell carcinoma

Efficacy and safety evaluation of immunotherapy combined with targeted therapy as second-line treatment in patients with metastatic non-clear cell renal cell carcinoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: August 14, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026